Related Experiment Video
Updated: May 4, 2026
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Published on: July 5, 2019
The application of 3D cell models to support drug safety assessment: opportunities & challenges
1F. Hoffmann-La Roche Ltd., Pharma Research, 4070 Basel, Switzerland.
Abstract:
The selection of drug candidates early in development has become increasingly important to minimize the use of animals and to avoid costly failures of drugs later in development. In vitro systems to predict and assess organ toxicity have so far been of limited value due to difficulties in demonstrating in vivo-relevant toxicity at a cell culture level. To overcome the limitations of single-cell type monolayer cultures and short-lived primary cell preparations, researchers have created novel 3-dimensional culture systems which appear to more closely resemble in vivo biology. These could become a key for the pharmaceutical industry in the evaluation of drug candidates. However, the value and acceptance of those new models in standard drug safety applications have yet to be demonstrated. This review aims to provide an overview of the different approaches undertaken in the field of pre-clinical safety assessment, organ toxicity, in particular, with an emphasis on examples and technical challenges.
Insights
Novel 3D culture systems show promise for predicting organ toxicity in drug development, potentially reducing animal use and late-stage failures. Their value in standard drug safety testing requires further validation.
Area of Science:
- Pre-clinical drug safety assessment
- Toxicology
- In vitro models
Background:
- Early drug candidate selection is crucial to minimize animal use and costly late-stage failures.
- Current in vitro systems for organ toxicity assessment have limited in vivo relevance.
- Limitations of traditional monolayer cultures and short-lived primary cells necessitate advanced models.
Purpose of the Study:
- To review novel 3D culture systems for pre-clinical organ toxicity assessment.
- To highlight challenges and examples in developing in vivo-relevant in vitro models.
- To evaluate the potential of these advanced models for pharmaceutical drug evaluation.
Main Methods:
- Review of current literature on 3D organoid and organ-on-a-chip technologies.
- Analysis of approaches to demonstrate in vivo-relevant toxicity in cell culture.
- Emphasis on technical challenges in implementing novel culture systems.
Main Results:
- 3D culture systems more closely mimic in vivo biology compared to traditional methods.
- These advanced models offer potential for improved prediction of organ toxicity.
- Widespread acceptance in standard drug safety applications is still pending.
Conclusions:
- Novel 3D culture systems represent a significant advancement in pre-clinical safety assessment.
- Further validation is needed to establish the reliability and acceptance of these models.
- These systems could become pivotal for the pharmaceutical industry in evaluating drug candidates.
More Related Videos
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
06:40A Robust Method for the Large-Scale Production of Spheroids for High-Content Screening and Analysis Applications
Published on: December 28, 2021
